Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sorrento Therapeutics Inc SRNE

Healthcare Biotechnology
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G... see more

Recent & Breaking News (GREY:SRNE)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

Newsfile June 17, 2020

Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm

Newsfile June 17, 2020

SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Sorrento Therapeutics, Inc.

GlobeNewswire June 16, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

ACCESSWIRE IA June 15, 2020

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE

GlobeNewswire June 15, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA June 13, 2020

Pomerantz Law Firm Announces the Filing of a Class Action against Sorrento Therapeutics, Inc. and Certain Officers - SRNE

GlobeNewswire June 12, 2020

SRNE INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That It Has Filed a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm Before July 27

Business Wire June 12, 2020

Sorrento Announces Full Repayment of Outstanding Term Loans

GlobeNewswire June 12, 2020

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA June 12, 2020

SRNE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors to Contact the Firm

ACCESSWIRE IA June 12, 2020

Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm

Newsfile June 11, 2020

SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Sorrento Therapeutics, Inc.

PR Newswire June 11, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

Newsfile June 10, 2020

Sorrento Announces It Has Submitted an Emergency Use Authorization (EUA) Application for the COVI-TRACK Diagnostic Test for the Detection of Antibodies to SARS-CoV-2

GlobeNewswire June 10, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sorrento Therapeutics, Inc. - SRNE

ACCESSWIRE IA June 10, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CytomX, Hamilton Beach Brands, Colony Capital, and Sorrento Therapeutics and Encourages Investors to Contact the Firm

GlobeNewswire June 10, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA June 10, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sorrento Therapeutics, Inc. - SRNE

GlobeNewswire June 8, 2020

SRNE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors to Contact the Firm

ACCESSWIRE IA June 8, 2020